For research use only. Not for therapeutic Use.
WUN29654(Cat No.:I038350)is an experimental small molecule being studied for its potential therapeutic applications in the treatment of various diseases, particularly in the areas of oncology and immunology. Although specific details regarding its mechanism of action are limited, WUN29654 has been shown to interact with key molecular pathways involved in cell growth, apoptosis, and immune response. It is being investigated for its efficacy in inhibiting tumor progression, especially in cancers with dysregulated signaling.
Catalog Number | I038350 |
CAS Number | 2407829-65-4 |
Synonyms | WUN29654; WUN-29654; WUN 29654; |
Molecular Formula | C17H12N2O5 |
Purity | 98% |
Target | Ligands for E3 Ligase |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 2-(2,6-dioxopiperidin-3-yl)-5-hydroxybenzo[de]isoquinoline-1,3-dione |
InChI | InChI=1S/C17H12N2O5/c20-9-6-8-2-1-3-10-14(8)11(7-9)17(24)19(16(10)23)12-4-5-13(21)18-15(12)22/h1-3,6-7,12,20H,4-5H2,(H,18,21,22) |
InChIKey | WGTKYDFLBDSIPX-UHFFFAOYSA-N |
SMILES | C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC4=CC(=CC(=C43)C2=O)O |